# Intragastric pH and Bismuth Effect for H. Pylori Eradication

> **NCT02894892** · NA · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 21 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** (A)Bismuth
- **DRUG:** (B)Bismuth
- **DRUG:** (C)Bismuth
- **DRUG:** (D)Esomeprazole and Bismuth
- **DRUG:** (E)Esomeprazole and Bismuth
- **DRUG:** (F)Esomeprazole and Bismuth
- **OTHER:** (G)Control

## Key facts

- **NCT ID:** NCT02894892
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-15
- **Primary completion:** 2017-10-18
- **Final completion:** 2019-02-20
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02894892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02894892, "Intragastric pH and Bismuth Effect for H. Pylori Eradication". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02894892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*